NCT05829473 is a NA clinical trial of Breathing Exercise Group in Hyperemesis Gravidarum, sponsored by Gaziantep Islam Science and Technology University.

Who is sponsoring NCT05829473?

NCT05829473 is sponsored by Gaziantep Islam Science and Technology University.

What drugs are being tested in NCT05829473?

Interventions in NCT05829473: Breathing Exercise Group, Guided Imagery Group.

What condition does NCT05829473 study?

NCT05829473 studies Hyperemesis Gravidarum.

Is NCT05829473 still recruiting?

NCT05829473 is currently status unknown. Last updated 25 April 2023.

Last reviewed 2023-04-25 · How we verify

NCT05829473

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Guided Imagery and Diaphragmatic Breathing Exercise in Pregnant Women With Hyperemesis Gravidarum

Status unknown NA Last updated 25 April 2023

What this trial tests

NA trial testing Breathing Exercise Group in Hyperemesis Gravidarum in 180 participants. Status unknown.

Timeline

30 April 2023

Primary endpoint
30 July 2023

15 August 2023

Quick facts

Lead sponsor	Gaziantep Islam Science and Technology University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	supportive care
Enrollment	180
Start date	30 April 2023
Primary completion	30 July 2023
Estimated completion	15 August 2023

Drugs / interventions tested

Breathing Exercise Group
Guided Imagery Group

Conditions studied

Hyperemesis Gravidarum — all drugs for Hyperemesis Gravidarum →

Sponsor

Gaziantep Islam Science and Technology University

Who can join

19 and older, female only, with Hyperemesis Gravidarum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: The aim of the researchers is to determine the effects of guided imagery and diaphragmatic breathing exercise application on nausea, vomiting severity, and anxiety level in pregnant with hyperemesis gravidarum. Methods: This study was planned as a single-blind randomized controlled experimental study. It is planned to be conducted with 180 pregnant women to be randomized in a university hospital in Southeastern Anatolia between April 2023 and August 2023. Data will be collected using the "Descriptive Information Form", "Nausea-Vomiting Severity Assessment Test During Pregnancy" and "Pregnancy-Related Anxiety Scale-R2". Keywords: Anxiety, Hyperemesis Gravidarum, Nausea-Vomiting, Guided Imagery, Diaphragmatic Breathing Exercise, Nursing,

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of guided imagery, and breathing exercise device on nausea-vomiting, and anxiety in hyperemesis gravidarum.
Karacan E, Karacan E. · · 2026 · PMID 41531003 · DOI 10.1080/02646838.2026.2615083

Verify or expand the search:

Other trials of Breathing Exercise Group

Trials testing the same drug.

NCT07100041 — Use of Breathing Exercises and Stress Balls During Dressing Changes in Burn Patients · NA · completed

Other recruiting trials for Hyperemesis Gravidarum

Currently open trials in the same condition.

NCT06615843 — Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up · NA · recruiting

Other Gaziantep Islam Science and Technology University trials

Trials by the same sponsor.

NCT07155538 — Bed Bridge Test in Acute Stroke Patients · not yet recruiting
NCT07155161 — Backward Walking and Related Factors in Individuals With Stroke · not yet recruiting
NCT07150078 — Dual Task and Attention Deficit and Hyperactivity Disorder · completed
NCT07478562 — Thoracolumbar Fascia · NA · completed
NCT06785155 — AI Chatbot-Based Learning on Dry Eye and Eye Strain Knowledge · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05829473 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gaziantep Islam Science and Technology University
Last refreshed: 25 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05829473.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing